These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 15390184)
1. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer. Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184 [TBL] [Abstract][Full Text] [Related]
2. Benzo[a]pyrene diol epoxide-induced 9p21 aberrations associated with genetic predisposition to bladder cancer. Hazra A; Grossman HB; Zhu Y; Luo S; Spitz MR; Wu X Genes Chromosomes Cancer; 2004 Dec; 41(4):330-8. PubMed ID: 15390186 [TBL] [Abstract][Full Text] [Related]
3. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients. Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867 [TBL] [Abstract][Full Text] [Related]
4. Fluorescent in situ hybridization analysis in blood lymphocytes of lung cancer patients. Dave BJ; Risin SA; Spitz MR; Pathak S Anticancer Res; 1996; 16(3A):1187-92. PubMed ID: 8702234 [TBL] [Abstract][Full Text] [Related]
5. Numerical aberrations of chromosome 17 and the 9p21 locus are independent predictors of tumor recurrence in non-invasive transitional cell carcinoma of the urinary bladder. Krüger S; Mess F; Böhle A; Feller AC Int J Oncol; 2003 Jul; 23(1):41-8. PubMed ID: 12792774 [TBL] [Abstract][Full Text] [Related]
6. BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk. Zhu Y; Spitz MR; Zheng YL; Hong WK; Wu X Cancer; 2002 Aug; 95(3):563-8. PubMed ID: 12209748 [TBL] [Abstract][Full Text] [Related]
7. Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei. Wheeless LL; Reeder JE; Han R; O'Connell MJ; Frank IN; Cockett AT; Hopman AH Cytometry; 1994 Dec; 17(4):319-26. PubMed ID: 7875039 [TBL] [Abstract][Full Text] [Related]
8. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients. Panani AD; Babanaraki A; Malianga E; Roussos Ch Anticancer Res; 2004; 24(6):3857-61. PubMed ID: 15736422 [TBL] [Abstract][Full Text] [Related]
9. Benzo(a)pyrene diol epoxide-induced chromosome 9p21 aberrations are associated with increased risk of bladder cancer. Gu J; Horikawa Y; Chen M; Dinney CP; Wu X Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2445-50. PubMed ID: 18768515 [TBL] [Abstract][Full Text] [Related]
10. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder. Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537 [TBL] [Abstract][Full Text] [Related]
11. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology. Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894 [TBL] [Abstract][Full Text] [Related]
12. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer. Wu X; Zhao Y; Honn SE; Tomlinson GE; Minna JD; Hong WK; Spitz MR Cancer Res; 1998 Apr; 58(8):1605-8. PubMed ID: 9563468 [TBL] [Abstract][Full Text] [Related]
13. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization]. Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751 [TBL] [Abstract][Full Text] [Related]
14. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer. Yamamoto Y; Matsuyama H; Furuya T; Oga A; Yoshihiro S; Okuda M; Kawauchi S; Sasaki K; Naito K Clin Cancer Res; 2004 Oct; 10(19):6449-55. PubMed ID: 15475431 [TBL] [Abstract][Full Text] [Related]
15. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses. Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913 [TBL] [Abstract][Full Text] [Related]
17. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions. Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577 [TBL] [Abstract][Full Text] [Related]
18. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250 [TBL] [Abstract][Full Text] [Related]
19. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Wu X; Lippman SM; Lee JJ; Zhu Y; Wei QV; Thomas M; Hong WK; Spitz MR Cancer Res; 2002 May; 62(10):2813-8. PubMed ID: 12019158 [TBL] [Abstract][Full Text] [Related]
20. Is aneusomy of chromosome 9 alone a valid biomarker for urinary bladder cancer screening? Panani AD; Kozirakis D; Anastasiou J; Babanaraki A; Malovrouvas D; Roussos C Anticancer Res; 2006; 26(2A):1161-5. PubMed ID: 16619518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]